Fosphenytoin sodium
- Product NDC
- 68083-460
- 11-digit product format
- 680830460
- Labeler code
- 68083
- Product ID
- 68083-460_00f57b3c-3819-440e-a928-eeec0fee27aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosphenytoin sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA214926
- Marketing category
- ANDA
- Marketing start
- 2023-10-13
- Substance
- FOSPHENYTOIN SODIUM
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214926-001 | FOSPHENYTOIN SODIUM | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214926-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | a72a2bbeb626… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214926-001 | FOSPHENYTOIN SODIUM | EQ 50MG PHENYTOIN NA/ML | INJECTABLE / INJECTION | AP | 2023-10-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214926-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214926-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214926-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214926-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214926-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214926-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214926-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214926-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214926-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214926-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214926-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214926-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214926-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214926-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214926-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A214926-001 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214926-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A214926-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A214926-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214926-001 | AP | 1 | a72a2bbeb626… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214926-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Fosphenytoin sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FOSPHENYTOIN SODIUM | 50 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7VLR55452Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 49b08648-6a83-42c7-ae7b-80c29f2534fc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| be8c0c29-be12-4cae-8e3b-1c71ed6b952c | Product name | 2 | 20250626 |
| e3d31abf-5149-4e77-89a8-0dc73ec106f9 | Product name | 1 | 20210525 |
| b251e19b-cfda-4a5c-8c9c-f4dad5d55ecb | Product name | 2 | 20200303 |
| 031bbc61-0564-1f35-2716-aa5c1d139248 | Product name | 2 | 20141218 |
| cc830ceb-037c-a5c3-ee14-3d82c0e89e70 | Product name | 1 | 20140508 |
| eafc3fd3-6834-3129-5bbb-8a9a495691ab | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68083-460-01 | Fosphenytoin sodium | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 6 | |
| 68083-460-25 | Fosphenytoin sodium | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosphenytoin sodium | FOSPHENYTOIN SODIUM | GLENMARK PHARMACEUTICALS INC., USA | a0def32c-e693-43e5-9509-0cef9642441c | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 214926 ANDA214926 |
| Fosphenytoin sodium | FOSPHENYTOIN SODIUM | GLENMARK PHARMACEUTICALS INC., USA | bb38bc6a-99c7-4cda-b3f0-37f629d060cf | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 214926 ANDA214926 |
| Fosphenytoin Sodium | FOSPHENYTOIN SODIUM | Sagent Pharmaceuticals | e1dab8ad-cbf6-4273-92fa-02629de2abde | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | 214926 ANDA214926 |
| Fosphenytoin sodium | FOSPHENYTOIN SODIUM | Gland Pharma Limited | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 2023-10-17 | Boxed warning, Warnings, Adverse reactions | 214926 ANDA214926 68083-460 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1670200 | fosphenytoin sodium 150 MG (as PE 100 MG) per 2 ML Injection | PSN | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670195 | fosphenytoin sodium 750 MG (as PE 500 MG) per 10 ML Injection | PSN | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670195 | 10 ML fosphenytoin sodium 75 MG/ML Injection | SCD | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670200 | 2 ML fosphenytoin sodium 75 MG/ML Injection | SCD | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670200 | fosphenytoin sodium 100 MG PE per 2 ML Injection | SY | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670195 | fosphenytoin sodium 500 MG PE per 10 ML Injection | SY | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670200 | fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection | SY | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
| 1670195 | fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 500 MG per 10 ML) Injection | SY | 49b08648-6a83-42c7-ae7b-80c29f2534fc | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68083-460-01 | 68083046001 | 2 mL in 1 VIAL, SINGLE-DOSE | 2 ml | Historical | |||
| 68083-460-25 | 68083046025 | 25 VIAL, SINGLE-DOSE in 1 CARTON (68083-460-25) / 2 mL in 1 VIAL, SINGLE-DOSE (68083-460-01) | 2023-10-13 | No | No | Current |